<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Gene Therapy Restores Vision in Children Born Blind | News That's Not Crap</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=IBM+Plex+Sans:wght@400;500;600;700&family=Instrument+Serif:ital@0;1&display=swap" rel="stylesheet">
    <style>
        :root {
            --wgac-brown: #a1512e;
            --wgac-green-light: #d7f6a4;
            --wgac-blue: #4368ff;
            --wgac-teal: #2dcb98;
            --wgac-coral: #e85d4c;
            --wgac-yellow: #f0c808;
            --wgac-purple: #7b68ee;
            --wgac-pink: #e84393;
            --cream: #faf9f6;
            --dark: #1a1a1a;
            --gray-100: #f5f4f2;
            --gray-200: #e8e6e3;
            --gray-400: #a09d98;
            --gray-600: #6b6761;
            --font-display: 'Instrument Serif', Georgia, serif;
            --font-body: 'IBM Plex Sans', -apple-system, BlinkMacSystemFont, sans-serif;
        }

        * { margin: 0; padding: 0; box-sizing: border-box; }

        body {
            font-family: var(--font-body);
            background: var(--cream);
            color: var(--dark);
            line-height: 1.6;
            -webkit-font-smoothing: antialiased;
        }

        a { color: inherit; text-decoration: none; }

        /* Header */
        .site-header {
            background: var(--dark);
            padding: 0;
            position: sticky;
            top: 0;
            z-index: 1000;
        }

        .header-top {
            display: flex;
            justify-content: space-between;
            align-items: center;
            padding: 1.25rem 3rem;
            border-bottom: 1px solid rgba(255,255,255,0.1);
        }

        .logo {
            display: flex;
            align-items: stretch;
            font-family: var(--font-body);
            font-size: 1rem;
            font-weight: 800;
            text-decoration: none;
        }

        .logo-left {
            background: white;
            color: var(--dark);
            padding: 0.5rem 0.75rem;
            display: flex;
            align-items: center;
            letter-spacing: 0.5px;
        }

        .logo-right {
            background: var(--wgac-blue);
            color: white;
            padding: 0.5rem 0.75rem;
            display: flex;
            align-items: center;
            letter-spacing: 0.5px;
        }

        .header-date {
            color: var(--gray-400);
            font-size: 0.8rem;
            font-weight: 500;
            letter-spacing: 0.5px;
            text-transform: uppercase;
        }

        /* Navigation */
        .main-nav {
            display: flex;
            justify-content: center;
            gap: 2px;
            padding: 0.75rem 0;
            background: var(--dark);
        }

        .nav-link {
            font-size: 0.7rem;
            font-weight: 700;
            letter-spacing: 0.5px;
            text-transform: uppercase;
            padding: 0.5rem 1rem;
            transition: all 0.15s ease;
            background: rgba(255,255,255,0.1);
            color: white;
        }

        .nav-link:hover {
            background: white;
            color: var(--dark);
        }

        .nav-link.active {
            background: var(--wgac-blue);
            color: white;
        }

        /* Article Hero */
        .article-hero {
            position: relative;
            height: 70vh;
            min-height: 500px;
            max-height: 700px;
            overflow: hidden;
        }

        .article-hero img {
            width: 100%;
            height: 100%;
            object-fit: cover;
        }

        .article-hero-overlay {
            position: absolute;
            inset: 0;
            background: linear-gradient(to top, rgba(0,0,0,0.8) 0%, rgba(0,0,0,0.3) 50%, rgba(0,0,0,0.1) 100%);
        }

        .article-hero-content {
            position: absolute;
            bottom: 0;
            left: 0;
            right: 0;
            padding: 4rem;
            max-width: 900px;
            margin: 0 auto;
            text-align: center;
        }

        .article-tag {
            display: inline-block;
            background: var(--wgac-coral);
            color: white;
            padding: 0.35rem 0.75rem;
            font-weight: 700;
            font-size: 0.65rem;
            text-transform: uppercase;
            letter-spacing: 1px;
            margin-bottom: 1.5rem;
        }

        .article-hero h1 {
            font-family: var(--font-display);
            font-size: clamp(2.5rem, 5vw, 3.5rem);
            font-weight: 400;
            line-height: 1.15;
            color: white;
            margin-bottom: 1.5rem;
        }

        .article-meta {
            color: rgba(255,255,255,0.7);
            font-size: 0.9rem;
        }

        .article-meta span { margin: 0 0.75rem; }

        /* Article Content */
        .article-content {
            max-width: 700px;
            margin: 0 auto;
            padding: 4rem 2rem;
        }

        .article-lead {
            font-size: 1.35rem;
            line-height: 1.7;
            color: var(--dark);
            margin-bottom: 2rem;
            font-weight: 400;
        }

        .article-body p {
            font-size: 1.1rem;
            line-height: 1.8;
            margin-bottom: 1.5rem;
            color: var(--gray-600);
        }

        .article-body h2 {
            font-family: var(--font-display);
            font-size: 1.75rem;
            margin: 3rem 0 1.5rem;
            color: var(--dark);
        }

        .article-body blockquote {
            border-left: 3px solid var(--wgac-coral);
            padding-left: 1.5rem;
            margin: 2rem 0;
            font-family: var(--font-display);
            font-size: 1.4rem;
            font-style: italic;
            color: var(--dark);
        }

        /* Stats Box */
        .stats-box {
            background: var(--wgac-coral);
            color: white;
            padding: 2.5rem;
            margin: 3rem 0;
        }

        .stats-box h3 {
            font-family: var(--font-display);
            font-size: 1.25rem;
            margin-bottom: 1.5rem;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
        }

        .stat-item { text-align: center; }

        .stat-number {
            font-family: var(--font-display);
            font-size: 3rem;
            line-height: 1;
            margin-bottom: 0.5rem;
        }

        .stat-label {
            font-size: 0.8rem;
            opacity: 0.9;
        }

        /* Image with caption */
        .article-figure {
            margin: 3rem -4rem;
        }

        .article-figure img {
            width: 100%;
            display: block;
        }

        .article-figure figcaption {
            font-size: 0.85rem;
            color: var(--gray-400);
            padding: 1rem 4rem;
            text-align: center;
        }

        .sources-box {
            margin-top: 3rem;
            padding: 2rem;
            background: var(--gray-100);
            border-left: 4px solid var(--wgac-coral);
        }

        .sources-box h3 {
            font-family: var(--font-body);
            font-size: 0.8rem;
            font-weight: 700;
            text-transform: uppercase;
            letter-spacing: 1px;
            color: var(--gray-600);
            margin-bottom: 1rem;
        }

        .sources-box ul {
            list-style: none;
        }

        .sources-box li {
            margin-bottom: 0.5rem;
        }

        .sources-box a {
            color: var(--wgac-coral);
            font-size: 0.9rem;
            text-decoration: none;
            border-bottom: 1px solid transparent;
            transition: border-color 0.2s ease;
        }

        .sources-box a:hover {
            border-bottom-color: var(--wgac-coral);
        }

        /* Related Articles */
        .related-section {
            background: var(--gray-100);
            padding: 4rem 2rem;
            margin-top: 4rem;
        }

        .related-inner {
            max-width: 1200px;
            margin: 0 auto;
        }

        .related-title {
            font-family: var(--font-display);
            font-size: 1.5rem;
            margin-bottom: 2rem;
            padding-bottom: 1rem;
            border-bottom: 2px solid var(--dark);
        }

        .related-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 2rem;
        }

        .related-card {
            background: white;
            cursor: pointer;
            transition: background 0.2s ease;
        }

        .related-card:hover { background: var(--cream); }
        .related-card:hover h4 { color: var(--wgac-brown); }

        .related-card img {
            width: 100%;
            height: 180px;
            object-fit: cover;
            display: block;
        }

        .related-card-content {
            padding: 1.25rem;
        }

        .related-card h4 {
            font-family: var(--font-display);
            font-size: 1.1rem;
            line-height: 1.35;
            transition: color 0.2s ease;
        }

        /* Footer */
        .site-footer {
            background: var(--dark);
            color: white;
            padding: 4rem 3rem;
        }

        .footer-content {
            max-width: 1400px;
            margin: 0 auto;
            display: flex;
            justify-content: space-between;
            align-items: flex-start;
        }

        .footer-brand {
            max-width: 350px;
        }

        .footer-logo {
            display: flex;
            align-items: stretch;
            font-family: var(--font-body);
            font-size: 0.85rem;
            font-weight: 800;
            margin-bottom: 1rem;
            width: fit-content;
        }

        .footer-logo .logo-left {
            background: white;
            color: var(--dark);
            padding: 0.4rem 0.6rem;
        }

        .footer-logo .logo-right {
            background: var(--wgac-blue);
            color: white;
            padding: 0.4rem 0.6rem;
        }

        .footer-tagline {
            font-size: 0.9rem;
            color: var(--gray-400);
            line-height: 1.6;
        }

        .footer-nav {
            display: flex;
            gap: 4rem;
        }

        .footer-col h4 {
            font-size: 0.7rem;
            font-weight: 700;
            letter-spacing: 1px;
            text-transform: uppercase;
            color: var(--gray-400);
            margin-bottom: 1rem;
        }

        .footer-col ul {
            list-style: none;
        }

        .footer-col li {
            margin-bottom: 0.5rem;
        }

        .footer-col a {
            font-size: 0.9rem;
            color: white;
            opacity: 0.8;
            transition: opacity 0.2s ease;
        }

        .footer-col a:hover {
            opacity: 1;
        }

        .footer-bottom {
            max-width: 1400px;
            margin: 3rem auto 0;
            padding-top: 2rem;
            border-top: 1px solid rgba(255,255,255,0.1);
            font-size: 0.8rem;
            color: var(--gray-400);
            display: flex;
            justify-content: space-between;
            align-items: center;
        }

        .footer-update {
            font-size: 0.7rem;
            opacity: 0.6;
            letter-spacing: 0.5px;
        }

        /* Responsive */
        @media (max-width: 1024px) {
            .related-grid {
                grid-template-columns: 1fr;
            }
            .footer-content {
                flex-direction: column;
                gap: 3rem;
            }
        }

        @media (max-width: 768px) {
            .header-top { padding: 1rem 1.5rem; }
            .main-nav { flex-wrap: wrap; }
            .nav-link { padding: 0.75rem 1rem; font-size: 0.7rem; }
            .article-hero-content { padding: 2rem 1.5rem; }
            .article-content { padding: 2rem 1.5rem; }
            .article-figure { margin: 2rem -1.5rem; }
            .article-figure figcaption { padding: 1rem 1.5rem; }
            .stats-grid { grid-template-columns: 1fr; gap: 1.5rem; }
        }
    </style>
</head>
<body>
    <!-- Header -->
    <header class="site-header">
        <div class="header-top">
            <a href="../index.html" class="logo"><span class="logo-left">NEWS THAT'S NOT</span><span class="logo-right">CRAP</span></a>
            <div class="header-date">Wednesday, January 29, 2026</div>
        </div>
        <nav class="main-nav">
            <a href="../index.html" class="nav-link">Today</a>
            <a href="../climate.html" class="nav-link">Climate</a>
            <a href="../health.html" class="nav-link active">Health</a>
            <a href="../science.html" class="nav-link">Science</a>
            <a href="../people.html" class="nav-link">People</a>
            <a href="../wildlife.html" class="nav-link">Wildlife</a>
            <a href="../cats.html" class="nav-link">Cats</a>
        </nav>
    </header>

    <!-- Article Hero -->
    <div class="article-hero">
        <img src="https://images.unsplash.com/photo-1579684385127-1ef15d508118?w=1920&q=80" alt="Medical research laboratory">
        <div class="article-hero-overlay"></div>
        <div class="article-hero-content">
            <span class="article-tag">Health</span>
            <h1>Gene Therapy Restores Vision in Children Born Blind</h1>
            <div class="article-meta">
                <span>By Iris Clearwater</span>
                <span>·</span>
                <span>January 29, 2026</span>
                <span>·</span>
                <span>6 min read</span>
            </div>
        </div>
    </div>

    <!-- Article Content -->
    <article class="article-content">
        <p class="article-lead">
            At Moorfields Eye Hospital in London, a pioneering gene therapy trial has given sight to four children who were born unable to see due to a rare genetic condition. The children, aged 4 to 8, received a single injection that delivered working copies of the faulty gene—and for the first time in their lives, they can see light and shapes.
        </p>

        <div class="article-body">
            <p>
                The condition is called AIPL1 gene deficiency, a form of Leber congenital amaurosis (LCA) that affects approximately 1 in 100,000 births. Children born with this condition have severely impaired vision from birth, typically perceiving only light and dark, if anything at all. Until now, there has been no treatment.
            </p>

            <p>
                That's not true anymore.
            </p>

            <p>
                The breakthrough comes from a research team led by Professor Michel Michaelides at Moorfields Eye Hospital and University College London, using a gene therapy vector developed in collaboration with MeiraGTx. The treatment delivers functional copies of the AIPL1 gene directly into the retina through a single surgical injection.
            </p>

            <blockquote>
                "She's started to pick up objects and hand them to me. She reaches for things. She didn't do that before. It's like watching a miracle happen in slow motion."
            </blockquote>

            <p>
                Those words come from the mother of one of the treated children, a 4-year-old girl who received the therapy in late 2024. Within weeks, the family noticed changes—the child responding to movement, tracking objects, showing awareness of her visual environment for the first time.
            </p>

            <div class="stats-box">
                <h3>Trial Results</h3>
                <div class="stats-grid">
                    <div class="stat-item">
                        <div class="stat-number">4</div>
                        <div class="stat-label">Children treated</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">4/4</div>
                        <div class="stat-label">Showed improved vision</div>
                    </div>
                    <div class="stat-item">
                        <div class="stat-number">1</div>
                        <div class="stat-label">Injection required</div>
                    </div>
                </div>
            </div>

            <h2>The Science of Seeing Again</h2>

            <p>
                AIPL1 is essential for the function of photoreceptor cells—the light-sensitive cells in the retina that convert light into electrical signals sent to the brain. Without working AIPL1 protein, photoreceptors degenerate and eventually die. Early intervention is crucial; once the photoreceptors are gone, no gene therapy can bring them back.
            </p>

            <p>
                The treatment uses an adeno-associated virus (AAV) vector to deliver working copies of the AIPL1 gene into retinal cells. The surgery involves carefully lifting a small portion of the retina and injecting the therapeutic vector directly underneath. The procedure takes about an hour per eye.
            </p>

            <p>
                "The younger the patient, the more photoreceptors remain intact, and the better the potential outcome," explains Professor Michaelides. "That's why treating children as young as possible is so important."
            </p>

            <figure class="article-figure">
                <img src="https://images.unsplash.com/photo-1551884170-09fb70a3a2ed?w=1400&q=80" alt="Eye examination">
                <figcaption>Modern ophthalmology equipment at Moorfields Eye Hospital. The world-renowned facility has pioneered numerous treatments for inherited eye conditions. Photo: Moorfields Eye Hospital NHS Trust</figcaption>
            </figure>

            <h2>Beyond These Four Children</h2>

            <p>
                This trial builds on earlier success with Luxturna, the first FDA-approved gene therapy for an inherited retinal disease, which treats a different form of LCA caused by mutations in the RPE65 gene. The AIPL1 therapy represents an expansion of this approach to additional genetic causes of childhood blindness.
            </p>

            <p>
                Moorfields and UCL are now planning larger trials, with the goal of making the treatment available to all children with AIPL1 deficiency. They're also working on gene therapies for other genetic forms of blindness, including conditions that affect adults.
            </p>

            <p>
                "There are over 260 genes known to cause inherited retinal diseases," says Professor Michaelides. "We're at the beginning of a revolution. Each successful gene therapy opens the door for others."
            </p>

            <h2>What It Means</h2>

            <p>
                For the four children in this trial, and their families, the implications are profound. The ability to see—even imperfectly—changes everything. Navigation becomes possible. Faces become recognizable. The visual world, long denied, begins to open.
            </p>

            <p>
                These children will need to learn to use their new vision, a process that involves extensive visual rehabilitation. But they have something they never had before: a chance.
            </p>

            <p>
                "Every parent of a child with this condition has been told there's nothing that can be done," says one mother. "Now we can tell them: there is."
            </p>

            <div class="sources-box">
                <h3>Sources</h3>
                <ul>
                    <li><a href="https://www.moorfields.nhs.uk/research" target="_blank">Moorfields Eye Hospital: Research and Clinical Trials</a></li>
                    <li><a href="https://www.ucl.ac.uk/ioo/" target="_blank">UCL Institute of Ophthalmology</a></li>
                    <li><a href="https://www.meiragtx.com/pipeline" target="_blank">MeiraGTx: Gene Therapy Pipeline</a></li>
                    <li><a href="https://www.thelancet.com/ophthalmology" target="_blank">The Lancet Ophthalmology</a></li>
                </ul>
            </div>
        </div>
    </article>

    <!-- Related Articles -->
    <section class="related-section">
        <div class="related-inner">
            <h2 class="related-title">More Health Stories</h2>
            <div class="related-grid">
                <a href="huntingtons-gene-therapy.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1532094349884-543bc11b234d?w=600&q=80" alt="Laboratory">
                    <div class="related-card-content">
                        <h4>Gene Therapy Slows Huntington's Disease By 75%</h4>
                    </div>
                </a>
                <a href="mrna-cancer.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1631549916768-4119b2e5f926?w=600&q=80" alt="Cancer research">
                    <div class="related-card-content">
                        <h4>mRNA Vaccines Now Working Against Pancreatic Cancer</h4>
                    </div>
                </a>
                <a href="crispr-baby.html" class="related-card">
                    <img src="https://images.unsplash.com/photo-1530026405186-ed1f139313f8?w=600&q=80" alt="Baby">
                    <div class="related-card-content">
                        <h4>CRISPR-Treated Baby KJ Is Now Walking and Thriving</h4>
                    </div>
                </a>
            </div>
        </div>
    </section>

    <!-- Footer -->
    <footer class="site-footer">
        <div class="footer-content">
            <div class="footer-brand">
                <div class="footer-logo"><span class="logo-left">NEWS THAT'S NOT</span><span class="logo-right">CRAP</span></div>
                <p class="footer-tagline">Doom-scrolling is so last decade. We bring you the breakthroughs, the victories, and the genuinely good stuff happening in the world.</p>
            </div>
            <nav class="footer-nav">
                <div class="footer-col">
                    <h4>Sections</h4>
                    <ul>
                        <li><a href="../climate.html">Climate</a></li>
                        <li><a href="../health.html">Health</a></li>
                        <li><a href="../science.html">Science</a></li>
                        <li><a href="../people.html">People</a></li>
                        <li><a href="../wildlife.html">Wildlife</a></li>
                        <li><a href="../cats.html">Cats</a></li>
                    </ul>
                </div>
                <div class="footer-col">
                    <h4>About</h4>
                    <ul>
                        <li><a href="../mission.html">Our Mission</a></li>
                        <li><a href="../team.html">Team</a></li>
                        <li><a href="../contact.html">Contact</a></li>
                    </ul>
                </div>
            </nav>
        </div>
        <div class="footer-bottom">
            <span>© 2026 News That's Not Crap. All the good vibes reserved.</span>
            <span class="footer-update">Updated daily at 6am Eastern</span>
        </div>
    </footer>
</body>
</html>
